Quick Takeaways
- Dashyant Dhanak has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $3,626,532.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Dashyant Dhanak
- Location
- Wilmington, DE
- Summary
- The estimated net worth of Dashyant Dhanak is at least $3,626,532 dollars as of 11 Jun 2024. Dashyant Dhanak is the EVP & Chief Scientific Officer of INCYTE CORP and owns shares of INCYTE CORP (INCY) stock worth about $3.63M.
- Signature
- /s/ Jeffrey M. Held, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Dashyant Dhanak and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: INCYTE CORP ($3,626,532).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Dashyant Dhanak
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| INCY | INCYTE CORP | EVP & Chief Scientific Officer | $3,626,532 | 14 Jul 2023 | ||
| Deciphera Pharmaceuticals, Inc. | EVP & Chief Scientific Officer | $0 | 11 Jun 2024 |
Insider Transactions Reported by Dashyant Dhanak:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.